Large study shows COVID-19 drug hydroxychloroquine is ineffective

There has been a lot of confusion regarding the effectiveness of the drug “hydroxychloroquine” in helping patients with mild COVID-19 symptoms. Most recently, a large study conducted by researchers in Brazil (published in The New England Journal of Medicine) reveals that hydroxychloroquine in combination with azithromycin (an antibiotic) didn’t improve the conditions of the hospitalized patients with moderate symptoms.

The study involved surveying 665 patients (divided into 3 groups) in 55 hospitals in Brazil. The first group of patients (217 patients) received hydroxychloroquine and azithromycin, the second group (221 patients) received only hydroxychloroquine, and the third group (227 patients) was a control (not receiving either drug), only given with general clinical support.

Read Also: Big Pharma plans on profiting from COVID-19 vaccine, won’t sell at cost

15 days later, 69%, 64%, and 68% of the first, second, and third group of patients (respectively) were sent home and didn’t face any limitations with breathing. The death rate was also consistent among all three groups, 3 percent. Though there were no positive effects of taking the drug, there were a few patients that faced more frequent changes in ECG tests and possible liver damage.

Hydroxychloroquine has faced a lot of skepticism from the public, especially when politicians continued in large favor of the drug for a long time. Until now, there is no FDA approved COVID-19 drug or vaccine. There have also been studies that have showed hydroxychloroquine causing cardiac toxicity in patients, some studies even claiming that the hydroxychloroquine causes more deaths than cures.

The World Health Organization (WHO) even halted hydroxychloroquine drug trials for a safety review. There are two sides to this debate, however. In June, researchers retracted a controversial study on the drug, after other scientists claimed that it could be misleading.

Until now, remdesivir seems to be the most potent candidate for an official COVID-19 drug. There have been studies that showed that remdesivir can shorten patient hospital stays and help people recover faster. Remdesiver is a drug developed by Gilead Sciences originally for the Ebola outbreak.

All of this proves that there is still a lot we don’t know about hydroxychloroquine. There are still many more studies being conducted by scientists around the world regarding the effectiveness of the drug in various circumstances and combinations. We won’t know until more data is revealed at the end of ongoing studies.

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

More from Health – News Landed

+ The new mutant variant of SARS-CoV-2 appears is more infectious and dominates the globe
+ Fertility in women to decline after coronavirus pandemic, new study says

Popular Stories – News Landed

+ Too much iron in your body reduces life expectancy, new study indicates
+ Revolutionary mid-infrared detector developed using silicon-based camera

Related Stories

The Covid-19 booster shot might be required to further strengthen the Immune system…

The COVID-19 pandemic took the lives of many and snatched the livelihoods at the same time can only be...

Scientists unveil the cause behind the positive RT-PCR results for COVID-19 after fine recovery

The novel COVID-19 virus continues to wreak havoc among all people in the world. Several studies have done and...

Featured Stories

India is one of the largest producers of COVID vaccine and yet faces major internal shortages

The worsening situation in India finally gained some stabilization around September 2020. Usually, when things start getting better, people...

The US supports easing patent rules on Covid-19 after intense internal debate…

Since the coming of the pandemic, there has been a lot of debates and questions around the Covid-19 vaccines....

Itziar Ituno says farewell to Inspector Lisbon in Money Heist

After Pedro Alonso (Berlin), Miguel Herrán (Rio), and Jaime Lorente (Denver), it is now Itziar Ituño who has fastened...

Abell 3827 Galaxy Cluster – Another stunning image from Hubble

You are looking at one of the stunning images of the galaxy cluster Abell 3827 taken by the Hubble...

Russia produced the World’s First Covid vaccine for animals

Russia has produced the first batch of Covid vaccine for animals, said the country's agriculture regulator announced on Friday....

Scientists use liquid biopsy for finding residual cancer DNA

Cancer patients who go through surgery for tumor removal may occasionally require chemotherapy as there can be high chances...